May 26, 2023 / 05:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to SMS Pharmaceuticals Limited Q4 FY23 earnings conference call. This conference call may contain forward-looking statements about the company, which are based on the belief, opinions, and expectations of the company as on date of this call. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict.
As a reminder, all participant lines will be in listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. (Operator Instructions)
I now hand the conference over to Mr. Vamsi Krishna Potluri, Executive Director of SMS Pharmaceuticals Limited. Thank you, and over to you, sir.
Vamsi Krishna Potluri - SMS Pharmaceuticals Ltd. - Executive Director
Good morning, everyone. Thank you for joining the earnings conference call to discuss financial performance for the quarter and year ended March 31, 2023. I hope everyone must have got an opportunity to go through our financial results and investor
Q4 2023 SMS Pharmaceuticals Ltd Earnings Call Transcript
May 26, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers